nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—breast cancer	0.198	0.538	CbGaD
Hydrocodone—CYP3A4—breast cancer	0.17	0.462	CbGaD
Hydrocodone—CYP3A4—Exemestane—breast cancer	0.0388	0.103	CbGbCtD
Hydrocodone—CYP2D6—Idarubicin—breast cancer	0.035	0.093	CbGbCtD
Hydrocodone—CYP3A4—Letrozole—breast cancer	0.033	0.0876	CbGbCtD
Hydrocodone—CYP3A4—Anastrozole—breast cancer	0.0294	0.0781	CbGbCtD
Hydrocodone—CYP3A4—Toremifene—breast cancer	0.0269	0.0714	CbGbCtD
Hydrocodone—CYP3A4—Fulvestrant—breast cancer	0.025	0.0664	CbGbCtD
Hydrocodone—CYP3A4—Thiotepa—breast cancer	0.0223	0.0592	CbGbCtD
Hydrocodone—CYP3A4—Ixabepilone—breast cancer	0.0204	0.0541	CbGbCtD
Hydrocodone—CYP3A4—Lapatinib—breast cancer	0.0196	0.0521	CbGbCtD
Hydrocodone—CYP2D6—Vinorelbine—breast cancer	0.0171	0.0454	CbGbCtD
Hydrocodone—CYP2D6—Tamoxifen—breast cancer	0.0154	0.041	CbGbCtD
Hydrocodone—CYP3A4—Raloxifene—breast cancer	0.0149	0.0395	CbGbCtD
Hydrocodone—CYP3A4—Vinorelbine—breast cancer	0.0109	0.0289	CbGbCtD
Hydrocodone—CYP2D6—Vinblastine—breast cancer	0.0105	0.028	CbGbCtD
Hydrocodone—CYP3A4—Tamoxifen—breast cancer	0.00982	0.0261	CbGbCtD
Hydrocodone—CYP3A4—Mitoxantrone—breast cancer	0.00958	0.0254	CbGbCtD
Hydrocodone—CYP3A4—Paclitaxel—breast cancer	0.00765	0.0203	CbGbCtD
Hydrocodone—CYP3A4—Irinotecan—breast cancer	0.00754	0.02	CbGbCtD
Hydrocodone—CYP3A4—Vinblastine—breast cancer	0.00671	0.0178	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—breast cancer	0.00648	0.0172	CbGbCtD
Hydrocodone—CYP3A4—Docetaxel—breast cancer	0.00553	0.0147	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—breast cancer	0.00412	0.0109	CbGbCtD
Hydrocodone—Galantamine—ACHE—breast cancer	0.000403	0.0906	CrCbGaD
Hydrocodone—Methylnaltrexone—CYP2D6—breast cancer	0.000253	0.0568	CrCbGaD
Hydrocodone—Galantamine—BCHE—breast cancer	0.000237	0.0533	CrCbGaD
Hydrocodone—Naloxone—ESR1—breast cancer	0.000231	0.0519	CrCbGaD
Hydrocodone—Dihydrocodeine—CYP2D6—breast cancer	0.000215	0.0483	CrCbGaD
Hydrocodone—Hydromorphone—PTGS1—breast cancer	0.0002	0.045	CrCbGaD
Hydrocodone—Oxymorphone—CYP2D6—breast cancer	0.000188	0.0423	CrCbGaD
Hydrocodone—Dihydrocodeine—CYP3A4—breast cancer	0.000184	0.0414	CrCbGaD
Hydrocodone—Ethylmorphine—CYP2D6—breast cancer	0.00018	0.0404	CrCbGaD
Hydrocodone—Oxymorphone—CYP3A4—breast cancer	0.000162	0.0363	CrCbGaD
Hydrocodone—Ethylmorphine—CYP3A4—breast cancer	0.000154	0.0347	CrCbGaD
Hydrocodone—Oxycodone—CYP2D6—breast cancer	0.00015	0.0338	CrCbGaD
Hydrocodone—Codeine—CYP2D6—breast cancer	0.000143	0.0322	CrCbGaD
Hydrocodone—Hydromorphone—CYP2D6—breast cancer	0.000136	0.0307	CrCbGaD
Hydrocodone—Naltrexone—ABCB1—breast cancer	0.000135	0.0302	CrCbGaD
Hydrocodone—Galantamine—CYP2D6—breast cancer	0.00013	0.0292	CrCbGaD
Hydrocodone—Oxycodone—CYP3A4—breast cancer	0.000129	0.029	CrCbGaD
Hydrocodone—Codeine—CYP3A4—breast cancer	0.000123	0.0276	CrCbGaD
Hydrocodone—Naloxone—CYP3A4—breast cancer	0.000118	0.0265	CrCbGaD
Hydrocodone—Hydromorphone—CYP3A4—breast cancer	0.000117	0.0263	CrCbGaD
Hydrocodone—Morphine—CYP2D6—breast cancer	0.000116	0.0261	CrCbGaD
Hydrocodone—Galantamine—CYP3A4—breast cancer	0.000112	0.0251	CrCbGaD
Hydrocodone—Naloxone—ALB—breast cancer	0.000103	0.0231	CrCbGaD
Hydrocodone—Morphine—CYP3A4—breast cancer	9.95e-05	0.0224	CrCbGaD
Hydrocodone—Hyperhidrosis—Paclitaxel—breast cancer	9.94e-05	0.000523	CcSEcCtD
Hydrocodone—Drowsiness—Methotrexate—breast cancer	9.85e-05	0.000518	CcSEcCtD
Hydrocodone—Naloxone—ABCB1—breast cancer	9.81e-05	0.022	CrCbGaD
Hydrocodone—Dextromethorphan—CYP2D6—breast cancer	9.74e-05	0.0219	CrCbGaD
Hydrocodone—Vomiting—Vinorelbine—breast cancer	9.72e-05	0.000511	CcSEcCtD
Hydrocodone—Body temperature increased—Gemcitabine—breast cancer	9.71e-05	0.00051	CcSEcCtD
Hydrocodone—Tremor—Capecitabine—breast cancer	9.69e-05	0.000509	CcSEcCtD
Hydrocodone—Dizziness—Thiotepa—breast cancer	9.66e-05	0.000508	CcSEcCtD
Hydrocodone—Rash—Vinorelbine—breast cancer	9.64e-05	0.000507	CcSEcCtD
Hydrocodone—Dermatitis—Vinorelbine—breast cancer	9.63e-05	0.000506	CcSEcCtD
Hydrocodone—Hypotension—Paclitaxel—breast cancer	9.61e-05	0.000505	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Epirubicin—breast cancer	9.61e-05	0.000505	CcSEcCtD
Hydrocodone—Headache—Vinorelbine—breast cancer	9.58e-05	0.000504	CcSEcCtD
Hydrocodone—Body temperature increased—Fluorouracil—breast cancer	9.55e-05	0.000502	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Paclitaxel—breast cancer	9.37e-05	0.000493	CcSEcCtD
Hydrocodone—Cough—Docetaxel—breast cancer	9.32e-05	0.00049	CcSEcCtD
Hydrocodone—Insomnia—Paclitaxel—breast cancer	9.3e-05	0.000489	CcSEcCtD
Hydrocodone—Hypersensitivity—Mitoxantrone—breast cancer	9.29e-05	0.000488	CcSEcCtD
Hydrocodone—Hypersensitivity—Irinotecan—breast cancer	9.29e-05	0.000488	CcSEcCtD
Hydrocodone—Vomiting—Thiotepa—breast cancer	9.28e-05	0.000488	CcSEcCtD
Hydrocodone—Convulsion—Docetaxel—breast cancer	9.25e-05	0.000487	CcSEcCtD
Hydrocodone—Paraesthesia—Paclitaxel—breast cancer	9.24e-05	0.000485	CcSEcCtD
Hydrocodone—Drowsiness—Epirubicin—breast cancer	9.22e-05	0.000485	CcSEcCtD
Hydrocodone—Rash—Thiotepa—breast cancer	9.21e-05	0.000484	CcSEcCtD
Hydrocodone—Dermatitis—Thiotepa—breast cancer	9.2e-05	0.000484	CcSEcCtD
Hydrocodone—Agranulocytosis—Methotrexate—breast cancer	9.19e-05	0.000483	CcSEcCtD
Hydrocodone—Dyspnoea—Paclitaxel—breast cancer	9.17e-05	0.000482	CcSEcCtD
Hydrocodone—Headache—Thiotepa—breast cancer	9.15e-05	0.000481	CcSEcCtD
Hydrocodone—Somnolence—Paclitaxel—breast cancer	9.14e-05	0.000481	CcSEcCtD
Hydrocodone—Arthralgia—Docetaxel—breast cancer	9.09e-05	0.000478	CcSEcCtD
Hydrocodone—Myalgia—Docetaxel—breast cancer	9.09e-05	0.000478	CcSEcCtD
Hydrocodone—Nausea—Vinorelbine—breast cancer	9.08e-05	0.000477	CcSEcCtD
Hydrocodone—Asthenia—Irinotecan—breast cancer	9.05e-05	0.000476	CcSEcCtD
Hydrocodone—Asthenia—Mitoxantrone—breast cancer	9.05e-05	0.000476	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	9.03e-05	0.000475	CcSEcCtD
Hydrocodone—Cough—Capecitabine—breast cancer	9.02e-05	0.000474	CcSEcCtD
Hydrocodone—Urinary tract infection—Epirubicin—breast cancer	8.96e-05	0.000471	CcSEcCtD
Hydrocodone—Hypersensitivity—Fluorouracil—breast cancer	8.9e-05	0.000468	CcSEcCtD
Hydrocodone—Dry mouth—Docetaxel—breast cancer	8.89e-05	0.000468	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—breast cancer	8.89e-05	0.000467	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Paclitaxel—breast cancer	8.88e-05	0.000467	CcSEcCtD
Hydrocodone—Fatigue—Paclitaxel—breast cancer	8.87e-05	0.000466	CcSEcCtD
Hydrocodone—Asthenia—Gemcitabine—breast cancer	8.81e-05	0.000463	CcSEcCtD
Hydrocodone—Myalgia—Capecitabine—breast cancer	8.8e-05	0.000463	CcSEcCtD
Hydrocodone—Arthralgia—Capecitabine—breast cancer	8.8e-05	0.000463	CcSEcCtD
Hydrocodone—Constipation—Paclitaxel—breast cancer	8.8e-05	0.000462	CcSEcCtD
Hydrocodone—Anxiety—Capecitabine—breast cancer	8.77e-05	0.000461	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	8.74e-05	0.00046	CcSEcCtD
Hydrocodone—Pruritus—Gemcitabine—breast cancer	8.69e-05	0.000457	CcSEcCtD
Hydrocodone—Nausea—Thiotepa—breast cancer	8.67e-05	0.000456	CcSEcCtD
Hydrocodone—Dry mouth—Capecitabine—breast cancer	8.61e-05	0.000453	CcSEcCtD
Hydrocodone—Agranulocytosis—Epirubicin—breast cancer	8.6e-05	0.000452	CcSEcCtD
Hydrocodone—Nervous system disorder—Docetaxel—breast cancer	8.55e-05	0.000449	CcSEcCtD
Hydrocodone—Pruritus—Fluorouracil—breast cancer	8.55e-05	0.000449	CcSEcCtD
Hydrocodone—Thrombocytopenia—Docetaxel—breast cancer	8.54e-05	0.000449	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—breast cancer	8.53e-05	0.000448	CcSEcCtD
Hydrocodone—Skin disorder—Docetaxel—breast cancer	8.47e-05	0.000445	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Paclitaxel—breast cancer	8.41e-05	0.000442	CcSEcCtD
Hydrocodone—Dextromethorphan—CYP3A4—breast cancer	8.36e-05	0.0188	CrCbGaD
Hydrocodone—Dizziness—Irinotecan—breast cancer	8.34e-05	0.000438	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—breast cancer	8.29e-05	0.000436	CcSEcCtD
Hydrocodone—Morphine—ABCB1—breast cancer	8.28e-05	0.0186	CrCbGaD
Hydrocodone—Nervous system disorder—Capecitabine—breast cancer	8.28e-05	0.000435	CcSEcCtD
Hydrocodone—Thrombocytopenia—Capecitabine—breast cancer	8.26e-05	0.000434	CcSEcCtD
Hydrocodone—Skin disorder—Capecitabine—breast cancer	8.2e-05	0.000431	CcSEcCtD
Hydrocodone—Hyperhidrosis—Capecitabine—breast cancer	8.16e-05	0.000429	CcSEcCtD
Hydrocodone—Oedema peripheral—Epirubicin—breast cancer	8.15e-05	0.000429	CcSEcCtD
Hydrocodone—Hypotension—Docetaxel—breast cancer	8.15e-05	0.000428	CcSEcCtD
Hydrocodone—Connective tissue disorder—Epirubicin—breast cancer	8.13e-05	0.000428	CcSEcCtD
Hydrocodone—Body temperature increased—Paclitaxel—breast cancer	8.13e-05	0.000427	CcSEcCtD
Hydrocodone—Abdominal pain—Paclitaxel—breast cancer	8.13e-05	0.000427	CcSEcCtD
Hydrocodone—Angiopathy—Methotrexate—breast cancer	8.02e-05	0.000422	CcSEcCtD
Hydrocodone—Vomiting—Mitoxantrone—breast cancer	8.02e-05	0.000422	CcSEcCtD
Hydrocodone—Vomiting—Irinotecan—breast cancer	8.02e-05	0.000422	CcSEcCtD
Hydrocodone—Dizziness—Fluorouracil—breast cancer	7.99e-05	0.00042	CcSEcCtD
Hydrocodone—Mediastinal disorder—Methotrexate—breast cancer	7.97e-05	0.000419	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—breast cancer	7.96e-05	0.000418	CcSEcCtD
Hydrocodone—Rash—Mitoxantrone—breast cancer	7.95e-05	0.000418	CcSEcCtD
Hydrocodone—Rash—Irinotecan—breast cancer	7.95e-05	0.000418	CcSEcCtD
Hydrocodone—Dermatitis—Irinotecan—breast cancer	7.94e-05	0.000418	CcSEcCtD
Hydrocodone—Dermatitis—Mitoxantrone—breast cancer	7.94e-05	0.000418	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Docetaxel—breast cancer	7.94e-05	0.000418	CcSEcCtD
Hydrocodone—Headache—Mitoxantrone—breast cancer	7.9e-05	0.000415	CcSEcCtD
Hydrocodone—Headache—Irinotecan—breast cancer	7.9e-05	0.000415	CcSEcCtD
Hydrocodone—Hypotension—Capecitabine—breast cancer	7.89e-05	0.000415	CcSEcCtD
Hydrocodone—Insomnia—Docetaxel—breast cancer	7.88e-05	0.000414	CcSEcCtD
Hydrocodone—Paraesthesia—Docetaxel—breast cancer	7.83e-05	0.000412	CcSEcCtD
Hydrocodone—Vomiting—Gemcitabine—breast cancer	7.81e-05	0.000411	CcSEcCtD
Hydrocodone—Dyspnoea—Docetaxel—breast cancer	7.77e-05	0.000409	CcSEcCtD
Hydrocodone—Somnolence—Docetaxel—breast cancer	7.75e-05	0.000407	CcSEcCtD
Hydrocodone—Mental disorder—Methotrexate—breast cancer	7.75e-05	0.000407	CcSEcCtD
Hydrocodone—Rash—Gemcitabine—breast cancer	7.75e-05	0.000407	CcSEcCtD
Hydrocodone—Dermatitis—Gemcitabine—breast cancer	7.74e-05	0.000407	CcSEcCtD
Hydrocodone—Malnutrition—Methotrexate—breast cancer	7.7e-05	0.000405	CcSEcCtD
Hydrocodone—Headache—Gemcitabine—breast cancer	7.7e-05	0.000405	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Capecitabine—breast cancer	7.69e-05	0.000404	CcSEcCtD
Hydrocodone—Vomiting—Fluorouracil—breast cancer	7.68e-05	0.000404	CcSEcCtD
Hydrocodone—Insomnia—Capecitabine—breast cancer	7.63e-05	0.000401	CcSEcCtD
Hydrocodone—Rash—Fluorouracil—breast cancer	7.62e-05	0.0004	CcSEcCtD
Hydrocodone—Dermatitis—Fluorouracil—breast cancer	7.61e-05	0.0004	CcSEcCtD
Hydrocodone—Paraesthesia—Capecitabine—breast cancer	7.58e-05	0.000398	CcSEcCtD
Hydrocodone—Hypersensitivity—Paclitaxel—breast cancer	7.58e-05	0.000398	CcSEcCtD
Hydrocodone—Headache—Fluorouracil—breast cancer	7.57e-05	0.000398	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—breast cancer	7.54e-05	0.000397	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Docetaxel—breast cancer	7.53e-05	0.000396	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—breast cancer	7.53e-05	0.000396	CcSEcCtD
Hydrocodone—Dyspnoea—Capecitabine—breast cancer	7.52e-05	0.000396	CcSEcCtD
Hydrocodone—Fatigue—Docetaxel—breast cancer	7.52e-05	0.000395	CcSEcCtD
Hydrocodone—Angiopathy—Epirubicin—breast cancer	7.51e-05	0.000395	CcSEcCtD
Hydrocodone—Nausea—Irinotecan—breast cancer	7.49e-05	0.000394	CcSEcCtD
Hydrocodone—Nausea—Mitoxantrone—breast cancer	7.49e-05	0.000394	CcSEcCtD
Hydrocodone—Mediastinal disorder—Epirubicin—breast cancer	7.46e-05	0.000392	CcSEcCtD
Hydrocodone—Constipation—Docetaxel—breast cancer	7.45e-05	0.000392	CcSEcCtD
Hydrocodone—Back pain—Methotrexate—breast cancer	7.45e-05	0.000391	CcSEcCtD
Hydrocodone—Asthenia—Paclitaxel—breast cancer	7.38e-05	0.000388	CcSEcCtD
Hydrocodone—Nausea—Gemcitabine—breast cancer	7.3e-05	0.000384	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Capecitabine—breast cancer	7.29e-05	0.000383	CcSEcCtD
Hydrocodone—Fatigue—Capecitabine—breast cancer	7.28e-05	0.000383	CcSEcCtD
Hydrocodone—Pruritus—Paclitaxel—breast cancer	7.28e-05	0.000383	CcSEcCtD
Hydrocodone—Mental disorder—Epirubicin—breast cancer	7.25e-05	0.000381	CcSEcCtD
Hydrocodone—Constipation—Capecitabine—breast cancer	7.22e-05	0.000379	CcSEcCtD
Hydrocodone—Malnutrition—Epirubicin—breast cancer	7.2e-05	0.000379	CcSEcCtD
Hydrocodone—Nausea—Fluorouracil—breast cancer	7.17e-05	0.000377	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Docetaxel—breast cancer	7.13e-05	0.000375	CcSEcCtD
Hydrocodone—Back pain—Epirubicin—breast cancer	6.97e-05	0.000366	CcSEcCtD
Hydrocodone—Dextromethorphan—ABCB1—breast cancer	6.96e-05	0.0156	CrCbGaD
Hydrocodone—Angiopathy—Doxorubicin—breast cancer	6.95e-05	0.000365	CcSEcCtD
Hydrocodone—Muscle spasms—Epirubicin—breast cancer	6.93e-05	0.000364	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Capecitabine—breast cancer	6.9e-05	0.000363	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—breast cancer	6.9e-05	0.000363	CcSEcCtD
Hydrocodone—Abdominal pain—Docetaxel—breast cancer	6.89e-05	0.000362	CcSEcCtD
Hydrocodone—Body temperature increased—Docetaxel—breast cancer	6.89e-05	0.000362	CcSEcCtD
Hydrocodone—Dizziness—Paclitaxel—breast cancer	6.8e-05	0.000358	CcSEcCtD
Hydrocodone—Cough—Methotrexate—breast cancer	6.72e-05	0.000353	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—breast cancer	6.71e-05	0.000353	CcSEcCtD
Hydrocodone—Abdominal pain—Capecitabine—breast cancer	6.67e-05	0.000351	CcSEcCtD
Hydrocodone—Body temperature increased—Capecitabine—breast cancer	6.67e-05	0.000351	CcSEcCtD
Hydrocodone—Convulsion—Methotrexate—breast cancer	6.67e-05	0.000351	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—breast cancer	6.67e-05	0.00035	CcSEcCtD
Hydrocodone—Myalgia—Methotrexate—breast cancer	6.55e-05	0.000345	CcSEcCtD
Hydrocodone—Arthralgia—Methotrexate—breast cancer	6.55e-05	0.000345	CcSEcCtD
Hydrocodone—Vomiting—Paclitaxel—breast cancer	6.54e-05	0.000344	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.51e-05	0.000342	CcSEcCtD
Hydrocodone—Rash—Paclitaxel—breast cancer	6.48e-05	0.000341	CcSEcCtD
Hydrocodone—Dermatitis—Paclitaxel—breast cancer	6.48e-05	0.000341	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—breast cancer	6.45e-05	0.000339	CcSEcCtD
Hydrocodone—Headache—Paclitaxel—breast cancer	6.44e-05	0.000339	CcSEcCtD
Hydrocodone—Hypersensitivity—Docetaxel—breast cancer	6.42e-05	0.000338	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—breast cancer	6.41e-05	0.000337	CcSEcCtD
Hydrocodone—Cough—Epirubicin—breast cancer	6.29e-05	0.00033	CcSEcCtD
Hydrocodone—Asthenia—Docetaxel—breast cancer	6.25e-05	0.000329	CcSEcCtD
Hydrocodone—Convulsion—Epirubicin—breast cancer	6.24e-05	0.000328	CcSEcCtD
Hydrocodone—Hypersensitivity—Capecitabine—breast cancer	6.22e-05	0.000327	CcSEcCtD
Hydrocodone—Pruritus—Docetaxel—breast cancer	6.17e-05	0.000324	CcSEcCtD
Hydrocodone—Nervous system disorder—Methotrexate—breast cancer	6.16e-05	0.000324	CcSEcCtD
Hydrocodone—Thrombocytopenia—Methotrexate—breast cancer	6.15e-05	0.000323	CcSEcCtD
Hydrocodone—Myalgia—Epirubicin—breast cancer	6.13e-05	0.000322	CcSEcCtD
Hydrocodone—Arthralgia—Epirubicin—breast cancer	6.13e-05	0.000322	CcSEcCtD
Hydrocodone—Anxiety—Epirubicin—breast cancer	6.11e-05	0.000321	CcSEcCtD
Hydrocodone—Nausea—Paclitaxel—breast cancer	6.11e-05	0.000321	CcSEcCtD
Hydrocodone—Skin disorder—Methotrexate—breast cancer	6.1e-05	0.000321	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.09e-05	0.00032	CcSEcCtD
Hydrocodone—Hyperhidrosis—Methotrexate—breast cancer	6.07e-05	0.000319	CcSEcCtD
Hydrocodone—Asthenia—Capecitabine—breast cancer	6.06e-05	0.000318	CcSEcCtD
Hydrocodone—Dry mouth—Epirubicin—breast cancer	6e-05	0.000315	CcSEcCtD
Hydrocodone—Pruritus—Capecitabine—breast cancer	5.97e-05	0.000314	CcSEcCtD
Hydrocodone—Hypotension—Methotrexate—breast cancer	5.87e-05	0.000309	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—breast cancer	5.82e-05	0.000306	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—breast cancer	5.78e-05	0.000304	CcSEcCtD
Hydrocodone—Nervous system disorder—Epirubicin—breast cancer	5.77e-05	0.000303	CcSEcCtD
Hydrocodone—Dizziness—Docetaxel—breast cancer	5.76e-05	0.000303	CcSEcCtD
Hydrocodone—Thrombocytopenia—Epirubicin—breast cancer	5.76e-05	0.000303	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Methotrexate—breast cancer	5.72e-05	0.000301	CcSEcCtD
Hydrocodone—Skin disorder—Epirubicin—breast cancer	5.71e-05	0.0003	CcSEcCtD
Hydrocodone—Hyperhidrosis—Epirubicin—breast cancer	5.68e-05	0.000299	CcSEcCtD
Hydrocodone—Insomnia—Methotrexate—breast cancer	5.68e-05	0.000299	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—breast cancer	5.68e-05	0.000298	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—breast cancer	5.68e-05	0.000298	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—breast cancer	5.66e-05	0.000297	CcSEcCtD
Hydrocodone—Paraesthesia—Methotrexate—breast cancer	5.64e-05	0.000297	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.64e-05	0.000296	CcSEcCtD
Hydrocodone—Dyspnoea—Methotrexate—breast cancer	5.6e-05	0.000294	CcSEcCtD
Hydrocodone—Somnolence—Methotrexate—breast cancer	5.59e-05	0.000294	CcSEcCtD
Hydrocodone—Dizziness—Capecitabine—breast cancer	5.58e-05	0.000293	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—breast cancer	5.55e-05	0.000292	CcSEcCtD
Hydrocodone—Vomiting—Docetaxel—breast cancer	5.54e-05	0.000291	CcSEcCtD
Hydrocodone—Rash—Docetaxel—breast cancer	5.5e-05	0.000289	CcSEcCtD
Hydrocodone—Hypotension—Epirubicin—breast cancer	5.49e-05	0.000289	CcSEcCtD
Hydrocodone—Dermatitis—Docetaxel—breast cancer	5.49e-05	0.000289	CcSEcCtD
Hydrocodone—Headache—Docetaxel—breast cancer	5.46e-05	0.000287	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Methotrexate—breast cancer	5.42e-05	0.000285	CcSEcCtD
Hydrocodone—Fatigue—Methotrexate—breast cancer	5.42e-05	0.000285	CcSEcCtD
Hydrocodone—Vomiting—Capecitabine—breast cancer	5.37e-05	0.000282	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Epirubicin—breast cancer	5.36e-05	0.000282	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—breast cancer	5.34e-05	0.00028	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—breast cancer	5.33e-05	0.00028	CcSEcCtD
Hydrocodone—Rash—Capecitabine—breast cancer	5.32e-05	0.00028	CcSEcCtD
Hydrocodone—Insomnia—Epirubicin—breast cancer	5.32e-05	0.00028	CcSEcCtD
Hydrocodone—Dermatitis—Capecitabine—breast cancer	5.32e-05	0.00028	CcSEcCtD
Hydrocodone—Headache—Capecitabine—breast cancer	5.29e-05	0.000278	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—breast cancer	5.28e-05	0.000278	CcSEcCtD
Hydrocodone—Paraesthesia—Epirubicin—breast cancer	5.28e-05	0.000278	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—breast cancer	5.26e-05	0.000276	CcSEcCtD
Hydrocodone—Dyspnoea—Epirubicin—breast cancer	5.24e-05	0.000276	CcSEcCtD
Hydrocodone—Somnolence—Epirubicin—breast cancer	5.23e-05	0.000275	CcSEcCtD
Hydrocodone—Nausea—Docetaxel—breast cancer	5.18e-05	0.000272	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Methotrexate—breast cancer	5.14e-05	0.00027	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—breast cancer	5.08e-05	0.000267	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Epirubicin—breast cancer	5.08e-05	0.000267	CcSEcCtD
Hydrocodone—Fatigue—Epirubicin—breast cancer	5.07e-05	0.000266	CcSEcCtD
Hydrocodone—Constipation—Epirubicin—breast cancer	5.03e-05	0.000264	CcSEcCtD
Hydrocodone—Nausea—Capecitabine—breast cancer	5.01e-05	0.000264	CcSEcCtD
Hydrocodone—Abdominal pain—Methotrexate—breast cancer	4.97e-05	0.000261	CcSEcCtD
Hydrocodone—Body temperature increased—Methotrexate—breast cancer	4.97e-05	0.000261	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.96e-05	0.000261	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—breast cancer	4.92e-05	0.000259	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—breast cancer	4.89e-05	0.000257	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—breast cancer	4.85e-05	0.000255	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—breast cancer	4.84e-05	0.000254	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Epirubicin—breast cancer	4.81e-05	0.000253	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—breast cancer	4.7e-05	0.000247	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—breast cancer	4.69e-05	0.000247	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—breast cancer	4.65e-05	0.000245	CcSEcCtD
Hydrocodone—Body temperature increased—Epirubicin—breast cancer	4.65e-05	0.000244	CcSEcCtD
Hydrocodone—Abdominal pain—Epirubicin—breast cancer	4.65e-05	0.000244	CcSEcCtD
Hydrocodone—Hypersensitivity—Methotrexate—breast cancer	4.63e-05	0.000243	CcSEcCtD
Hydrocodone—Asthenia—Methotrexate—breast cancer	4.51e-05	0.000237	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—breast cancer	4.45e-05	0.000234	CcSEcCtD
Hydrocodone—Pruritus—Methotrexate—breast cancer	4.45e-05	0.000234	CcSEcCtD
Hydrocodone—Hypersensitivity—Epirubicin—breast cancer	4.33e-05	0.000228	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—breast cancer	4.3e-05	0.000226	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—breast cancer	4.3e-05	0.000226	CcSEcCtD
Hydrocodone—Asthenia—Epirubicin—breast cancer	4.22e-05	0.000222	CcSEcCtD
Hydrocodone—Pruritus—Epirubicin—breast cancer	4.16e-05	0.000219	CcSEcCtD
Hydrocodone—Dizziness—Methotrexate—breast cancer	4.15e-05	0.000218	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—breast cancer	4.01e-05	0.000211	CcSEcCtD
Hydrocodone—Vomiting—Methotrexate—breast cancer	3.99e-05	0.00021	CcSEcCtD
Hydrocodone—Rash—Methotrexate—breast cancer	3.96e-05	0.000208	CcSEcCtD
Hydrocodone—Dermatitis—Methotrexate—breast cancer	3.96e-05	0.000208	CcSEcCtD
Hydrocodone—Headache—Methotrexate—breast cancer	3.94e-05	0.000207	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—breast cancer	3.9e-05	0.000205	CcSEcCtD
Hydrocodone—Dizziness—Epirubicin—breast cancer	3.89e-05	0.000204	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—breast cancer	3.85e-05	0.000202	CcSEcCtD
Hydrocodone—Vomiting—Epirubicin—breast cancer	3.74e-05	0.000197	CcSEcCtD
Hydrocodone—Nausea—Methotrexate—breast cancer	3.73e-05	0.000196	CcSEcCtD
Hydrocodone—Rash—Epirubicin—breast cancer	3.71e-05	0.000195	CcSEcCtD
Hydrocodone—Dermatitis—Epirubicin—breast cancer	3.7e-05	0.000195	CcSEcCtD
Hydrocodone—Headache—Epirubicin—breast cancer	3.68e-05	0.000194	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—breast cancer	3.6e-05	0.000189	CcSEcCtD
Hydrocodone—Nausea—Epirubicin—breast cancer	3.49e-05	0.000184	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—breast cancer	3.46e-05	0.000182	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—breast cancer	3.43e-05	0.00018	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—breast cancer	3.43e-05	0.00018	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—breast cancer	3.41e-05	0.000179	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—breast cancer	3.23e-05	0.00017	CcSEcCtD
Hydrocodone—OPRD1—Signaling Pathways—SERPINE1—breast cancer	8.05e-06	0.000133	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGF—breast cancer	8.02e-06	0.000133	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LDHB—breast cancer	8.02e-06	0.000133	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HPSE—breast cancer	8.02e-06	0.000133	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—BRIP1—breast cancer	8.02e-06	0.000133	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—KRAS—breast cancer	7.97e-06	0.000132	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HPGDS—breast cancer	7.91e-06	0.000131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGFR1—breast cancer	7.91e-06	0.000131	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HBA1—breast cancer	7.86e-06	0.00013	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HIF1A—breast cancer	7.79e-06	0.000129	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—MAPK3—breast cancer	7.77e-06	0.000128	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOS3—breast cancer	7.68e-06	0.000127	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ACHE—breast cancer	7.67e-06	0.000127	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTT1—breast cancer	7.67e-06	0.000127	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—BRAF—breast cancer	7.63e-06	0.000126	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMMR—breast cancer	7.6e-06	0.000126	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA3—breast cancer	7.6e-06	0.000126	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCC1—breast cancer	7.6e-06	0.000126	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LEP—breast cancer	7.6e-06	0.000126	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CAV1—breast cancer	7.53e-06	0.000124	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KDR—breast cancer	7.45e-06	0.000123	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF1—breast cancer	7.43e-06	0.000123	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT2—breast cancer	7.43e-06	0.000123	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EGFR—breast cancer	7.4e-06	0.000122	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.36e-06	0.000122	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CA—breast cancer	7.32e-06	0.000121	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MDM2—breast cancer	7.29e-06	0.00012	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RAF1—breast cancer	7.27e-06	0.00012	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP17A1—breast cancer	7.26e-06	0.00012	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ESR1—breast cancer	7.26e-06	0.00012	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RELA—breast cancer	7.23e-06	0.00012	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ERBB2—breast cancer	7.19e-06	0.000119	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ENO1—breast cancer	7.19e-06	0.000119	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS1—breast cancer	7.19e-06	0.000119	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FN1—breast cancer	7.17e-06	0.000118	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CD—breast cancer	7.14e-06	0.000118	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CB—breast cancer	7.09e-06	0.000117	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MTOR—breast cancer	7.09e-06	0.000117	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NFKBIA—breast cancer	7.08e-06	0.000117	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CA—breast cancer	7.07e-06	0.000117	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SERPINE1—breast cancer	7.06e-06	0.000117	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH1—breast cancer	7.02e-06	0.000116	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—KRAS—breast cancer	6.99e-06	0.000115	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA4—breast cancer	6.96e-06	0.000115	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CA9—breast cancer	6.96e-06	0.000115	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NCOA2—breast cancer	6.92e-06	0.000114	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CG—breast cancer	6.86e-06	0.000113	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APC—breast cancer	6.86e-06	0.000113	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KIT—breast cancer	6.86e-06	0.000113	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL8—breast cancer	6.82e-06	0.000113	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGF—breast cancer	6.78e-06	0.000112	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA2—breast cancer	6.78e-06	0.000112	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX2—breast cancer	6.78e-06	0.000112	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HRAS—breast cancer	6.77e-06	0.000112	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOS3—breast cancer	6.74e-06	0.000111	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—FASN—breast cancer	6.71e-06	0.000111	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX4—breast cancer	6.69e-06	0.000111	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SULT1A1—breast cancer	6.69e-06	0.000111	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—BCHE—breast cancer	6.68e-06	0.00011	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1B—breast cancer	6.66e-06	0.00011	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC5A5—breast cancer	6.6e-06	0.000109	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT1—breast cancer	6.58e-06	0.000109	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MAPK3—breast cancer	6.57e-06	0.000109	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—IDH1—breast cancer	6.54e-06	0.000108	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTA1—breast cancer	6.54e-06	0.000108	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CASP3—breast cancer	6.52e-06	0.000108	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL2—breast cancer	6.51e-06	0.000108	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—breast cancer	6.48e-06	0.000107	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NAT2—breast cancer	6.47e-06	0.000107	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—BRAF—breast cancer	6.45e-06	0.000107	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	6.42e-06	0.000106	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MDM2—breast cancer	6.39e-06	0.000106	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NQO1—breast cancer	6.37e-06	0.000105	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC2A1—breast cancer	6.37e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RAF1—breast cancer	6.37e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCND1—breast cancer	6.35e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RELA—breast cancer	6.34e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—JUN—breast cancer	6.34e-06	0.000105	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ERBB2—breast cancer	6.3e-06	0.000104	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CTNNB1—breast cancer	6.29e-06	0.000104	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1—breast cancer	6.28e-06	0.000104	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT2—breast cancer	6.28e-06	0.000104	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EGFR—breast cancer	6.25e-06	0.000103	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MTOR—breast cancer	6.22e-06	0.000103	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CB—breast cancer	6.22e-06	0.000103	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP3A4—breast cancer	6.21e-06	0.000103	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—breast cancer	6.17e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CDKN1A—breast cancer	6.14e-06	0.000102	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTEN—breast cancer	6.13e-06	0.000101	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1B1—breast cancer	6.11e-06	0.000101	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CD—breast cancer	6.03e-06	9.97e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK8—breast cancer	6e-06	9.91e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HSP90AA1—breast cancer	5.99e-06	9.9e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT1—breast cancer	5.98e-06	9.88e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL8—breast cancer	5.98e-06	9.88e-05	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	5.97e-06	9.87e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SERPINE1—breast cancer	5.96e-06	9.86e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HRAS—breast cancer	5.94e-06	9.81e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—KRAS—breast cancer	5.9e-06	9.76e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1B—breast cancer	5.84e-06	9.65e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NCOA1—breast cancer	5.83e-06	9.63e-05	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT1—breast cancer	5.77e-06	9.54e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—STK11—breast cancer	5.74e-06	9.49e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP19A1—breast cancer	5.74e-06	9.49e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CASP3—breast cancer	5.72e-06	9.45e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL2—breast cancer	5.71e-06	9.44e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOS3—breast cancer	5.69e-06	9.41e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SRC—breast cancer	5.68e-06	9.39e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—breast cancer	5.68e-06	9.39e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MED12—breast cancer	5.67e-06	9.37e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—DPYD—breast cancer	5.67e-06	9.37e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALDOA—breast cancer	5.58e-06	9.22e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCND1—breast cancer	5.57e-06	9.2e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—JUN—breast cancer	5.56e-06	9.18e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—breast cancer	5.54e-06	9.15e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CTNNB1—breast cancer	5.51e-06	9.11e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT3—breast cancer	5.48e-06	9.06e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	5.42e-06	8.96e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOA3—breast cancer	5.42e-06	8.95e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—breast cancer	5.41e-06	8.93e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MDM2—breast cancer	5.4e-06	8.93e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CDKN1A—breast cancer	5.39e-06	8.9e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RAF1—breast cancer	5.38e-06	8.9e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC2A2—breast cancer	5.38e-06	8.89e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTEN—breast cancer	5.37e-06	8.88e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RELA—breast cancer	5.36e-06	8.86e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—COMT—breast cancer	5.34e-06	8.83e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ERBB2—breast cancer	5.33e-06	8.8e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTP1—breast cancer	5.32e-06	8.78e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCG2—breast cancer	5.27e-06	8.71e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CPT1A—breast cancer	5.27e-06	8.71e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTR—breast cancer	5.27e-06	8.71e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK8—breast cancer	5.26e-06	8.69e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CB—breast cancer	5.26e-06	8.69e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MTOR—breast cancer	5.26e-06	8.69e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT1—breast cancer	5.24e-06	8.67e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMOX1—breast cancer	5.24e-06	8.66e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MAPK3—breast cancer	5.24e-06	8.65e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ITPR1—breast cancer	5.23e-06	8.64e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HPGDS—breast cancer	5.17e-06	8.54e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HBA1—breast cancer	5.14e-06	8.49e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MYC—breast cancer	5.09e-06	8.42e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—breast cancer	5.08e-06	8.4e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL8—breast cancer	5.05e-06	8.35e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ABCB1—breast cancer	5.03e-06	8.32e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HRAS—breast cancer	5.02e-06	8.29e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ACHE—breast cancer	5.01e-06	8.29e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTT1—breast cancer	5.01e-06	8.29e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SRC—breast cancer	4.98e-06	8.24e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGFR—breast cancer	4.98e-06	8.23e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TYMS—breast cancer	4.94e-06	8.17e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1B—breast cancer	4.93e-06	8.15e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GSTM1—breast cancer	4.88e-06	8.07e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.88e-06	8.07e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NCOR1—breast cancer	4.88e-06	8.07e-05	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT1—breast cancer	4.88e-06	8.06e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—breast cancer	4.85e-06	8.02e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CASP3—breast cancer	4.83e-06	7.99e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL2—breast cancer	4.83e-06	7.98e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT3—breast cancer	4.81e-06	7.94e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—breast cancer	4.8e-06	7.94e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP17A1—breast cancer	4.75e-06	7.84e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KRAS—breast cancer	4.71e-06	7.78e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCND1—breast cancer	4.71e-06	7.78e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ENO1—breast cancer	4.7e-06	7.76e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS1—breast cancer	4.7e-06	7.76e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JUN—breast cancer	4.7e-06	7.76e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GPX1—breast cancer	4.68e-06	7.73e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CTNNB1—breast cancer	4.66e-06	7.7e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1A1—breast cancer	4.63e-06	7.65e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2D6—breast cancer	4.61e-06	7.61e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ERCC2—breast cancer	4.59e-06	7.59e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MAPK3—breast cancer	4.59e-06	7.59e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—breast cancer	4.57e-06	7.55e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CDKN1A—breast cancer	4.55e-06	7.52e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTEN—breast cancer	4.54e-06	7.51e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOA2—breast cancer	4.52e-06	7.47e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MYC—breast cancer	4.47e-06	7.38e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—breast cancer	4.46e-06	7.36e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK8—breast cancer	4.44e-06	7.34e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT1—breast cancer	4.43e-06	7.32e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—FASN—breast cancer	4.39e-06	7.25e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGFR—breast cancer	4.37e-06	7.22e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—BCHE—breast cancer	4.37e-06	7.22e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CA—breast cancer	4.32e-06	7.15e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—breast cancer	4.32e-06	7.13e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC5A5—breast cancer	4.31e-06	7.13e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SRC—breast cancer	4.21e-06	6.96e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TP53—breast cancer	4.18e-06	6.91e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC2A1—breast cancer	4.17e-06	6.89e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NQO1—breast cancer	4.17e-06	6.89e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KRAS—breast cancer	4.13e-06	6.82e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—breast cancer	4.1e-06	6.78e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT3—breast cancer	4.06e-06	6.71e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HRAS—breast cancer	4e-06	6.61e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1B1—breast cancer	3.99e-06	6.6e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CAV1—breast cancer	3.98e-06	6.58e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.92e-06	6.47e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MAPK3—breast cancer	3.88e-06	6.41e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—breast cancer	3.83e-06	6.33e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOA1—breast cancer	3.81e-06	6.3e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CA—breast cancer	3.79e-06	6.27e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MYC—breast cancer	3.77e-06	6.24e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—breast cancer	3.77e-06	6.22e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—STK11—breast cancer	3.76e-06	6.21e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP19A1—breast cancer	3.76e-06	6.21e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGFR—breast cancer	3.69e-06	6.1e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TP53—breast cancer	3.67e-06	6.06e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CG—breast cancer	3.63e-06	5.99e-05	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT1—breast cancer	3.53e-06	5.84e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HRAS—breast cancer	3.51e-06	5.8e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—COMT—breast cancer	3.49e-06	5.77e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KRAS—breast cancer	3.49e-06	5.76e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTP1—breast cancer	3.48e-06	5.74e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMOX1—breast cancer	3.43e-06	5.66e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ITPR1—breast cancer	3.42e-06	5.65e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—breast cancer	3.36e-06	5.55e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ABCB1—breast cancer	3.29e-06	5.44e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TYMS—breast cancer	3.23e-06	5.34e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CA—breast cancer	3.2e-06	5.3e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.19e-06	5.28e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GSTM1—breast cancer	3.19e-06	5.28e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOR1—breast cancer	3.19e-06	5.28e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CD—breast cancer	3.19e-06	5.27e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ALB—breast cancer	3.15e-06	5.2e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TP53—breast cancer	3.1e-06	5.12e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT1—breast cancer	3.1e-06	5.12e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX1—breast cancer	3.06e-06	5.05e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1A1—breast cancer	3.03e-06	5e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NOS3—breast cancer	3.01e-06	4.98e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ERCC2—breast cancer	3e-06	4.96e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HRAS—breast cancer	2.96e-06	4.9e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—breast cancer	2.84e-06	4.69e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—breast cancer	2.82e-06	4.66e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CB—breast cancer	2.78e-06	4.59e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS2—breast cancer	2.75e-06	4.55e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT1—breast cancer	2.62e-06	4.33e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CAV1—breast cancer	2.6e-06	4.3e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTEN—breast cancer	2.4e-06	3.97e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CG—breast cancer	2.37e-06	3.92e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CD—breast cancer	2.08e-06	3.45e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ALB—breast cancer	2.06e-06	3.4e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NOS3—breast cancer	1.97e-06	3.25e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CB—breast cancer	1.82e-06	3e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS2—breast cancer	1.8e-06	2.98e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CA—breast cancer	1.69e-06	2.8e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTEN—breast cancer	1.57e-06	2.59e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKT1—breast cancer	1.38e-06	2.29e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CA—breast cancer	1.11e-06	1.83e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKT1—breast cancer	9.05e-07	1.5e-05	CbGpPWpGaD
